Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sangamo Therapeutics (SGMO) Return on Assets (2016 - 2025)

Sangamo Therapeutics has reported Return on Assets over the past 15 years, most recently at 1.66% for Q4 2025.

  • Quarterly results put Return on Assets at 1.66% for Q4 2025, down 74.0% from a year ago — trailing twelve months through Dec 2025 was 1.66% (down 74.0% YoY), and the annual figure for FY2025 was 1.52%, down 79.0%.
  • Return on Assets for Q4 2025 was 1.66% at Sangamo Therapeutics, down from 1.17% in the prior quarter.
  • Over the last five years, Return on Assets for SGMO hit a ceiling of 0.14% in Q1 2021 and a floor of 2.25% in Q2 2024.
  • Median Return on Assets over the past 5 years was 0.6% (2025), compared with a mean of 0.8%.
  • Biggest five-year swings in Return on Assets: tumbled -198bps in 2024 and later surged 156bps in 2025.
  • Sangamo Therapeutics' Return on Assets stood at 0.24% in 2021, then plummeted by -39bps to 0.33% in 2022, then plummeted by -303bps to 1.34% in 2023, then surged by 31bps to 0.92% in 2024, then tumbled by -80bps to 1.66% in 2025.
  • The last three reported values for Return on Assets were 1.66% (Q4 2025), 1.17% (Q3 2025), and 0.69% (Q2 2025) per Business Quant data.